1-17 of 17
Wenqi Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Gao Yan, Hui-qiang Huang, MD PhD, Wang Xiaoxiao, Bai Bing, Pengfei Li, Hui Zhou, Zhi-gang Peng, Xiao-yan Ke, Kai-yang Ding, Yu Yang, MD, Sha-dong Min, Yue-rong Shuang, Li Zhiming, Cai Qingqing, Bingzong Li, MDPhD, Wenqi Jiang
Journal: Blood
Blood (2018)
https://doi.org/10.1182/blood-2018-99-116551
Published: 2018
Journal Articles

Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma

Weicheng Ren, Xiaofei Ye, Hong Su, Wei Li, Dongbing Liu, Mohammad Pirmoradian, Xianhuo Wang, Bo Zhang, Qiang Zhang, Longyun Chen, Man Nie, Yao Liu, Bin Meng, Huiqiang Huang, Wenqi Jiang, Yixin Zeng, Wenyu Li, Kui Wu, Yong Hou, Klas G. Wiman, Zhiming Li, Huilai Zhang, Roujun Peng, Shida Zhu, Qiang Pan-Hammarström
Journal: Blood
Blood (2018) 131 (24): 2670–2681.
https://doi.org/10.1182/blood-2017-11-817601
Published: 2018
Includes: Supplemental data
Journal Articles

Neutrophils Extracellular Traps Induced By Lymphoma-Derived IL-8 Could Promote Diffuse Large B Cell Lymphoma Progression

Man Nie, Linbing Yang, Xiwen Bi, Yu Wang, Peng Sun, Hang Yang, Panpan Liu, Zhiming Li, Yi Xia, Wenqi Jiang, Wenyu Li, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4029.
https://doi.org/10.1182/blood.V130.Suppl_1.4029.4029
Published: 2017
Journal Articles

The Therapeutic Response of Chidamide Was Associated with Elevated H3 Acetylation Level in Patients with Refractory/Relapsed Non-Hodgkin Lymphoma (R/R-NHL)

Hui-qiang Huang, MD PhD, Pengfei Li, Yan Gao, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Su Li, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 4080.
https://doi.org/10.1182/blood.V130.Suppl_1.4080.4080
Published: 2017
Journal Articles

Chidamide ,Oral Subtype-Selective Histone Deacetylase Inhibitor (HDACI) Monotherapy Was Effective on the Patients with Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma

Gao Yan, Hui-qiang Huang, Pengfei Li, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Li Zhiming, Cai Qingqing, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 2797.
https://doi.org/10.1182/blood.V130.Suppl_1.2797.2797
Published: 2017
Journal Articles

Pegaspargase Plus Gemcitabine, Oxaliplatin(P-Gemox) and Thalidomide Versus Aspermetdex Regimen for the Patients with Early or Advanced/Relapsed Extranodal Natural Killer/T Cell Lymphoma: Interim Analysis of a Prospective,Multicenter, Randomized, Phase III Non-Inferiority Clinical Trial

Yan Gao, Huiqiang Huang, MD, Yujing Zhang, Hang Su, Xiaoxiao Wang, Bing Bai, Yunhong Huang, Yuhuan Gao, Liping Su, MD, Xiaoxia Chu, Wenyu Li, Junyi Zhang, Qiaohua Zhang, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1819.
https://doi.org/10.1182/blood.V128.22.1819.1819
Published: 2016
Journal Articles

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Wei Zhao, Zheng Yan, Wenqi Jiang, MD PhD, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 1521.
https://doi.org/10.1182/blood.V126.23.1521.1521
Published: 2015
Journal Articles

R-EPOCH Is Superior to R-CHOP As a First-Line Regimen in De Novo DLBCL Patients with High Ki-67 Expression

Jia-Jia Huang, Wenqi Jiang, MD PhD, Zhi-Ming Li
Journal: Blood
Blood (2015) 126 (23): 5085.
https://doi.org/10.1182/blood.V126.23.5085.5085
Published: 2015
Journal Articles

Consolidative Treatment after Salvage Chemotherapy Improved Prognosis in Patients with Relapsed Extranodal Natural Killer/T-Cell Lymphoma

Xi-Wen Bi, Wen-Wen Zhang, Jia-Jia Huang, Zhongjun Xia, MD, Zhi-Ming Li, Wenqi Jiang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5086.
https://doi.org/10.1182/blood.V126.23.5086.5086
Published: 2015
Journal Articles

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Zheng Yan, Wenqi Jiang, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 3936.
https://doi.org/10.1182/blood.V126.23.3936.3936
Published: 2015
Journal Articles

A Novel and Significant Predictor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: The Prognostic Nutritional Index (PNI)

Qingqing Cai, MD PhD, Kailin Chen, MD, Huilan Rao, MDPhD, Wenqi Jiang, MD PhD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Zhongjun Xia, MD
Journal: Blood
Blood (2014) 124 (21): 1650.
https://doi.org/10.1182/blood.V124.21.1650.1650
Published: 2014
Journal Articles

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Qingqing Cai, MD PhD, Kailin Chen, MD, Qirong Geng, MD, Guangzheng Zhong, MD, Jianping Li, MD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Wenqi Jiang, MD PhD, Zhiming Li, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1655.
https://doi.org/10.1182/blood.V124.21.1655.1655
Published: 2014
Journal Articles

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Qingqing Cai, MD, PhD, Yiming Chen, MD., PhD., Dehui Zou, Maria Badillo, BS, Shouhao Zhou, PhD, Liang Zhang, MD, PhD, Elyse R Lopez, Wenqi Jiang, MD, PhD, Hui-qiang Huang, MD, PhD, Tongyu Lin, MD, PhD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 3056.
https://doi.org/10.1182/blood.V122.21.3056.3056
Published: 2013
Journal Articles

A New Prognostic Model for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Qingqing Cai, MD, PhD, Xiaolin Luo, MD, Ken H. Young, MD, Huiqiang Huang, MD, PhD, Guanrong Zhang, MD, Tongyu Lin, MD, PhD, Wenqi Jiang, MD, PhD, Zhongjun Xia, MD
Journal: Blood
Blood (2013) 122 (21): 1769.
https://doi.org/10.1182/blood.V122.21.1769.1769
Published: 2013
Journal Articles

Efficacy and Safety Of Pegaspargase With Gemcitabine and Oxaliplatin In Patients With Treatment-naïve, Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Single-Centre Experience

Yan Gao, M.D., Hui-qiang Huang, MD, PhD, Cai QiChun, XiaoXiao Wang, M.D., Ph.D., QinfQing Cai, Zhongjun Xia, MD, Bing Bai, Wei Zhao, Wenqi Jiang, MD, PhD, ZhongZhen Guan
Journal: Blood
Blood (2013) 122 (21): 642.
https://doi.org/10.1182/blood.V122.21.642.642
Published: 2013
Journal Articles

Long-Term Outcomes of Patients with Newly Diagnosed NK/T-Cell Lymphoma Treated by EPOCH Regimen.

Huiqiang Huang, Zexiao Lin, Xubing Lin, Qingqing Cai, Zhongjun Xia, MD, Wenqi Jiang
Journal: Blood
Blood (2009) 114 (22): 2689.
https://doi.org/10.1182/blood.V114.22.2689.2689
Published: 2009